An increased expression of the anti-inflammatory pro-tumor gene Ccl17 was observed only in the RLS40High subgroup, while, in DNase I-treated subgroups, Ccl17 mRNA expression was at the level observed in the healthy control (Figure 5C). Here, CCL17 is linked to neoplasm.